William Blair Comments on Neogen Co.'s FY2026 Earnings (NASDAQ:NEOG)

Neogen Co. (NASDAQ:NEOG - Free Report) - Analysts at William Blair issued their FY2026 earnings per share estimates for Neogen in a research note issued to investors on Tuesday, April 9th. William Blair analyst B. Vazquez anticipates that the company will post earnings of $0.64 per share for the year. The consensus estimate for Neogen's current full-year earnings is $0.50 per share.

Neogen (NASDAQ:NEOG - Get Free Report) last posted its earnings results on Tuesday, April 9th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.02). The business had revenue of $228.80 million for the quarter, compared to analysts' expectations of $230.01 million. Neogen had a net margin of 0.17% and a return on equity of 3.35%. Neogen's quarterly revenue was up 4.8% on a year-over-year basis. During the same period last year, the firm posted $0.12 earnings per share.

Separately, Piper Sandler lifted their target price on shares of Neogen from $17.50 to $19.00 and gave the company a "neutral" rating in a report on Thursday, January 18th.

Neogen Stock Down 4.8 %

Shares of NEOG stock traded down $0.62 during midday trading on Friday, reaching $12.38. 4,246,685 shares of the stock were exchanged, compared to its average volume of 2,092,976. The firm has a market cap of $2.68 billion, a PE ratio of 1,238.00 and a beta of 1.13. The company's 50 day moving average is $15.81 and its two-hundred day moving average is $16.72. Neogen has a 1 year low of $12.18 and a 1 year high of $24.09. The company has a current ratio of 3.82, a quick ratio of 2.63 and a debt-to-equity ratio of 0.28.

Institutional Investors Weigh In On Neogen

A number of large investors have recently made changes to their positions in the company. Raymond James Trust N.A. grew its position in Neogen by 6.7% during the first quarter. Raymond James Trust N.A. now owns 6,981 shares of the company's stock valued at $215,000 after buying an additional 441 shares during the period. United Services Automobile Association grew its position in shares of Neogen by 4.5% during the 2nd quarter. United Services Automobile Association now owns 13,988 shares of the company's stock valued at $304,000 after acquiring an additional 608 shares during the period. Raymond James Financial Services Advisors Inc. increased its stake in shares of Neogen by 5.8% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 12,900 shares of the company's stock worth $259,000 after purchasing an additional 711 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Neogen by 1.9% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 40,163 shares of the company's stock worth $968,000 after purchasing an additional 759 shares during the period. Finally, Sheets Smith Wealth Management lifted its position in Neogen by 2.6% during the fourth quarter. Sheets Smith Wealth Management now owns 30,795 shares of the company's stock valued at $619,000 after purchasing an additional 771 shares in the last quarter. 96.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Neogen

In other Neogen news, CEO John Edward Adent acquired 23,000 shares of Neogen stock in a transaction that occurred on Wednesday, April 10th. The stock was bought at an average cost of $12.36 per share, for a total transaction of $284,280.00. Following the acquisition, the chief executive officer now owns 152,389 shares of the company's stock, valued at $1,883,528.04. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO David H. Naemura purchased 12,500 shares of the company's stock in a transaction dated Wednesday, April 10th. The shares were purchased at an average cost of $12.51 per share, for a total transaction of $156,375.00. Following the purchase, the chief financial officer now directly owns 30,040 shares in the company, valued at approximately $375,800.40. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO John Edward Adent acquired 23,000 shares of Neogen stock in a transaction that occurred on Wednesday, April 10th. The shares were purchased at an average price of $12.36 per share, with a total value of $284,280.00. Following the transaction, the chief executive officer now owns 152,389 shares of the company's stock, valued at approximately $1,883,528.04. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 43,000 shares of company stock worth $538,605. Insiders own 0.71% of the company's stock.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.